| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 316.28B | 316.88B | 312.83B | 301.37B | 281.42B | 206.64B |
| Gross Profit | 134.82B | 129.33B | 126.70B | 117.90B | 102.58B | 61.34B |
| EBITDA | 34.37B | 34.15B | 37.18B | 34.76B | 33.46B | 1.83B |
| Net Income | 24.52B | 23.88B | 22.96B | 21.84B | 22.14B | -25.17B |
Balance Sheet | ||||||
| Total Assets | 418.97B | 415.55B | 415.44B | 389.98B | 394.96B | 365.81B |
| Cash, Cash Equivalents and Short-Term Investments | 98.99B | 93.75B | 81.31B | 82.59B | 110.90B | 101.82B |
| Total Debt | 68.26B | 69.99B | 81.35B | 70.96B | 67.24B | 75.98B |
| Total Liabilities | 156.42B | 151.40B | 159.31B | 157.20B | 156.29B | 152.94B |
| Stockholders Equity | 254.49B | 255.92B | 247.66B | 224.18B | 229.31B | 203.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 18.69B | 18.65B | 1.49B | 25.13B | -1.75B |
| Operating Cash Flow | 0.00 | 35.77B | 34.56B | 16.58B | 34.69B | 7.49B |
| Investing Cash Flow | 0.00 | -10.03B | -12.70B | -13.50B | -9.55B | -7.63B |
| Financing Cash Flow | 0.00 | -12.54B | -26.99B | -40.09B | -19.96B | 18.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥433.51B | 7.53 | 9.36% | 3.61% | 1.01% | 7.42% | |
74 Outperform | ¥9.63T | 14.11 | 13.39% | 2.29% | 9.62% | 25.71% | |
71 Outperform | ¥16.04T | 16.87 | 15.23% | 2.11% | 0.93% | 15.80% | |
69 Neutral | ¥7.25T | 15.10 | 12.86% | 2.48% | 3.19% | 72.26% | |
68 Neutral | ¥21.84T | 13.18 | 7.39% | 2.94% | -7.54% | -35.70% | |
67 Neutral | ¥18.66T | 17.68 | 11.47% | 2.28% | -1.33% | -7.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |